JPRN-UMIN000025624招募中2 期
Phase II study of EGFR-TKI in elderly patients with lung cancer harboring EGFR gene mutation in liquid biopsy - Phase II study of EGFR-TKI in elderly patients with lung cancer harboring EGFR gene mutation in liquid biopsy (ALCSG-03)
Respiratory Center. Asahikawa Medical University Hospital0 个研究点目标入组 26 人开始时间: 2017年2月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients are excluded if they have; (1)Severe concomitant disease. (2)Severe history of hypersensitivity. (3)Severe heart disease or arrhythmia. (4)Interstitial pneumonia. (5)Active infection. (6)Active peptic ulcer. (7)Active double cancer. (8)No measurable lesion.
研究者
相似试验
已完成
不适用
Clinical study of a combined use of EGFR-TKI and autologous lymphocyte-activated killer cells (LAK) therapy for advanced non-small cell lung cancer.non-small cell lung cancerJPRN-UMIN000001966Juntendo University, School of Medicine10
已完成
不适用
Phase II study of EGFR-TKI rechallenge with afatinib in advanced NSCLC patients haboring sensitive EGFR mutation without T790MJPRN-UMIN000015568Okayama University Hospital12
已完成
2 期
A Phase II Study of Pemetrexed and EGFR-TKI in Patients with Non-Small Cell Lung Cancer After Failing EGFR-TKIson-Small Cell Lung CancerJPRN-UMIN000003712Osaka Lung Cancer Study Group25
已完成
2 期
Multicenter phase II trial of continuous EGFR-TKIs for elderly patients with EGFR sensitive mutation who failed the first EGFR-TKIs treatment for advanced non-small cell lung cancer.JPRN-UMIN000008027ung Oncology Group in Kyushu, Japan (LOGIK)70
已完成
不适用
Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients with Anaplastic Astrocytoma or Glioblastoma: A Phase Ib Study (STEAM)glioblastomaNL-OMON50615European Organisation for Research in Treatment of Cancer (EORTC)22